Home > Healthcare > Medical Devices > Diagnostic Devices > Ovarian Cancer Diagnostic Market

Ovarian Cancer Diagnostic Market Share

Report ID: GMI8316
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Ovarian Cancer Diagnostic Market Share

The ovarian cancer diagnostic industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players including Abbott Laboratories, Danaher Corporation, F. Hoffmann-La Roche Ltd, Qiagen N.V. among others have a notable presence in the market.

Ovarian Cancer Diagnostic Market Companies

Some of the eminent market participants operating in the ovarian cancer diagnostic industry include:

Abbott Laboratories
Agilent Technologies
Canon Medical Systems Corporation
Danaher Corporation
F. Hoffmann-La Roche Ltd.
Fujirebio Diagnostics
GE HealthCare Technologies Inc.
Illumina Inc.
Myriad Genetics
Philips Healthcare
Positron Corporation
Qiagen N.V.
Quest Diagnostics
Siemens Healthineers AG

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global ovarian cancer diagnostic industry was valued at around USD 1.54 billion in 2023 and is estimated to reach over USD 2.71 billion by 2032, driven by increasing incidences of ovarian cancer worldwide.

Instruments/analyzers segment garnered USD 965.7 million in 2023 and is set to gain traction by 2032, driven by technological advancements and growing awareness about the importance of early detection and screening for ovarian cancer.

North America ovarian cancer diagnostic industry accounted for USD 624.4 million in 2023 and is predicted to witness substantial growth through 2032, driven by an advanced healthcare infrastructure and high levels of awareness regarding the importance of early cancer detection.

Abbott Laboratories, Agilent Technologies, Canon Medical Systems Corporation, Danaher Corporation, F. Hoffmann-La Roche Ltd., Fujirebio Diagnostics, GE HealthCare Technologies Inc., Illumina Inc., Myriad Genetics, Philips Healthcare, Positron Corporation are some of the major industry contenders.